These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 10954574)
1. Coinfection of SCID-hu Thy/Liv mice with human herpesvirus 6 and human immunodeficiency virus type 1. Gobbi A; Stoddart CA; Locatelli G; Santoro F; Bare C; Linquist-Stepps V; Moreno ME; Abbey NW; Herndier BG; Malnati MS; McCune JM; Lusso P J Virol; 2000 Sep; 74(18):8726-31. PubMed ID: 10954574 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of acute in vivo human immunodeficiency virus infection by human interleukin 10 treatment of SCID mice implanted with human fetal thymus and liver. Kollmann TR; Pettoello-Mantovani M; Katopodis NF; Hachamovitch M; Rubinstein A; Kim A; Goldstein H Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3126-31. PubMed ID: 8610180 [TBL] [Abstract][Full Text] [Related]
3. Saquinavir-mediated inhibition of human immunodeficiency virus (HIV) infection in SCID mice implanted with human fetal thymus and liver tissue: an in vivo model for evaluating the effect of drug therapy on HIV infection in lymphoid tissues. Pettoello-Mantovani M; Kollmann TR; Raker C; Kim A; Yurasov S; Tudor R; Wiltshire H; Goldstein H Antimicrob Agents Chemother; 1997 Sep; 41(9):1880-7. PubMed ID: 9303378 [TBL] [Abstract][Full Text] [Related]
4. Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1. Kollmann TR; Pettoello-Mantovani M; Zhuang X; Kim A; Hachamovitch M; Smarnworawong P; Rubinstein A; Goldstein H J Exp Med; 1994 Feb; 179(2):513-22. PubMed ID: 8294863 [TBL] [Abstract][Full Text] [Related]
5. HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model. Honeycutt JB; Wahl A; Archin N; Choudhary S; Margolis D; Garcia JV Retrovirology; 2013 Oct; 10():121. PubMed ID: 24156277 [TBL] [Abstract][Full Text] [Related]
6. Identification of HIV-1 determinants for replication in vivo. Su L; Kaneshima H; Bonyhadi ML; Lee R; Auten J; Wolf A; Du B; Rabin L; Hahn BH; Terwilliger E; Mccune JM Virology; 1997 Jan; 227(1):45-52. PubMed ID: 9007057 [TBL] [Abstract][Full Text] [Related]
8. Induction of human immunodeficiency virus 1 replication by human herpesvirus 8. Mercader M; Nickoloff BJ; Foreman KE Arch Pathol Lab Med; 2001 Jun; 125(6):785-9. PubMed ID: 11371231 [TBL] [Abstract][Full Text] [Related]
9. Impaired replication of protease inhibitor-resistant HIV-1 in human thymus. Stoddart CA; Liegler TJ; Mammano F; Linquist-Stepps VD; Hayden MS; Deeks SG; Grant RM; Clavel F; McCune JM Nat Med; 2001 Jun; 7(6):712-8. PubMed ID: 11385509 [TBL] [Abstract][Full Text] [Related]
10. Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds. Rabin L; Hincenbergs M; Moreno MB; Warren S; Linquist V; Datema R; Charpiot B; Seifert J; Kaneshima H; McCune JM Antimicrob Agents Chemother; 1996 Mar; 40(3):755-62. PubMed ID: 8851606 [TBL] [Abstract][Full Text] [Related]
11. Infection of gamma/delta T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection. Lusso P; Garzino-Demo A; Crowley RW; Malnati MS J Exp Med; 1995 Apr; 181(4):1303-10. PubMed ID: 7699322 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of human immunodeficiency virus 1 (HIV-1) by variant B of human herpesvirus 6 (HHV-6). Bonura F; Perna AM; Vitale F; Villafrate MR; Viviano E; Guttadauro R; Mazzola G; Romano N New Microbiol; 1999 Jul; 22(3):161-71. PubMed ID: 10423733 [TBL] [Abstract][Full Text] [Related]
13. Separation of human immunodeficiency virus type 1 replication from nef-mediated pathogenesis in the human thymus. Duus KM; Miller ED; Smith JA; Kovalev GI; Su L J Virol; 2001 Apr; 75(8):3916-24. PubMed ID: 11264380 [TBL] [Abstract][Full Text] [Related]
14. Human herpesvirus 6 (HHV-6) causes severe thymocyte depletion in SCID-hu Thy/Liv mice. Gobbi A; Stoddart CA; Malnati MS; Locatelli G; Santoro F; Abbey NW; Bare C; Linquist-Stepps V; Moreno MB; Herndier BG; Lusso P; McCune JM J Exp Med; 1999 Jun; 189(12):1953-60. PubMed ID: 10377191 [TBL] [Abstract][Full Text] [Related]
15. Development of a novel transgenic mouse/SCID-hu mouse system to characterize the in vivo behavior of reservoirs of human immunodeficiency virus type 1-infected cells. Wang EJ; Pettoello-Mantovani M; Anderson CM; Osiecki K; Moskowitz D; Goldstein H J Infect Dis; 2002 Nov; 186(10):1412-21. PubMed ID: 12404156 [TBL] [Abstract][Full Text] [Related]
16. Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice. Kollmann TR; Kim A; Pettoello-Mantovani M; Hachamovitch M; Rubinstein A; Goldstein MM; Goldstein H J Immunol; 1995 Jan; 154(2):907-21. PubMed ID: 7814892 [TBL] [Abstract][Full Text] [Related]
17. Activation of the signal transducer and activator of transcription 1 signaling pathway in thymocytes from HIV-1-infected human thymus. Miller ED; Smith JA; Lichtinger M; Wang L; Su L AIDS; 2003 Jun; 17(9):1269-77. PubMed ID: 12799548 [TBL] [Abstract][Full Text] [Related]
18. Suppression of human immunodeficiency virus type 1 replication by human herpesvirus-6. Carrigan DR; Knox KK; Tapper MA J Infect Dis; 1990 Oct; 162(4):844-51. PubMed ID: 2169498 [TBL] [Abstract][Full Text] [Related]
19. Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures. Asada H; Klaus-Kovtun V; Golding H; Katz SI; Blauvelt A J Virol; 1999 May; 73(5):4019-28. PubMed ID: 10196298 [TBL] [Abstract][Full Text] [Related]
20. Effect of latent human immunodeficiency virus infection on cell surface phenotype. Brooks DG; Zack JA J Virol; 2002 Feb; 76(4):1673-81. PubMed ID: 11799162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]